Home > Insider Trading > Filing (0001181431-12-053460)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1365216	Sucampo Pharmaceuticals Inc.	SCMP	Pharmaceutical Preparations (2834)	133929237

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1384384	S&R Technology Holdings, Llc	7501 Wisconsin Avenue Suite 600 Bethesda MD 20814-6519		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2012-08-30	26,191,050	$0.00	26,400,802	No	4	X	Direct
Class A Common Stock	Disposition	2012-10-01	38,450	$5.15	26,362,352	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Class B Common Stock	Disposition	2012-08-30	26,191,050	$0.00	26,191,050	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	X	Direct

Footnotes

Shares acquired upon conversion of shares of Class B Common Stock on a one-for-one basis.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.02 to $5.24, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Each share of Class B Common Stock is convertible at any time into one share of Class A Common Stock without further consideration.
Taking into account all applicable stock splits, S&R Technology Holdings, LLC obtained (i) 2,465,000 shares of Class B Common Stock for $290,000, (ii) 11,722,350 shares of Class B Common Stock for $2,413,425, and (iii) 12,003,700 shares of Class B Common Stock for $1,999,958.